RVMD
Revolution Medicines, Inc. · Healthcare · Market cap $41.6B
Insiders sold $78.0M net in the last 90 days ·9 sellers, 0 buyers· 19 of 19 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 1, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$154.1M
reported sales (SEC code S)
Unique Insiders
12
in the rolling window
Latest filing
Oct 1, 2026
Sandler Alan B.
Revolution Medicines, Inc. (RVMD) has 69 SEC Form 4 filings (215 transaction rows) in the rolling window, disclosed by 12 distinct insiders. Most recent filing: Oct 1, 2026.
Inside the rolling window, 12 insiders at Revolution Medicines, Inc. reported no open-market purchases and 58 open-market sales totaling $154.1M. The most active filer is See Remarks GOLDSMITH MARK A with 11 filings. Insiders have net sold $121.5M over the trailing 6 months. The most recent open-market filing is a sale of 6,309 shares by Chief Development Officer Sandler Alan B., dated Sep 29, 2026, worth $1.3M.
- Industry:Biotechnology
- CEO:Mark A. Goldsmith
- Employees:883
- HQ:Redwood City, CA, US
- IPO:2020-02-13
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Development Officer | Sale | 6,309 | $1.3M | Oct 1 | -5.6% | SEC ↗ | |
| SVP & General Counsel | Sale | 765 | $159K | Sep 29 | -5.0% | SEC ↗ | |
| See Remarks | Sale | 587 | $117K | Sep 28 | -3.7% | SEC ↗ | |
| See Remarks | Sale | 3,121 | $626K | Sep 28 | -3.7% | SEC ↗ | |
ANDERSON ELIZABETH MFirst in 10 months | Director | Sale | 10,143 | $2.0M | Sep 24 | -2.8% | SEC ↗ |
| See Remarks | Sale | 1,764 | $347K | Sep 22 | — | SEC ↗ | |
Sandler Alan B.First filing | Chief Development Officer | Sale | 341 | $68K | Sep 18 | — | SEC ↗ |
| See Remarks | Sale | 1,774 | $353K | Sep 18 | — | SEC ↗ | |
| See Remarks | Sale | 5,569 | $1.1M | Sep 18 | — | SEC ↗ | |
| See Remarks | Sale | 13,988 | $2.8M | Sep 18 | — | SEC ↗ | |
| SVP & General Counsel | Sale | 3,366 | $671K | Sep 18 | — | SEC ↗ | |
Horn Margaret AFirst in 3 months | Chief Operating Officer | Sale | 4,967 | $990K | Sep 18 | — | SEC ↗ |
| Chief Financial Officer | Sale | 4,053 | $808K | Sep 18 | — | SEC ↗ | |
| See Remarks | Sale | 92,531 | $18.7M | Sep 15 | — | SEC ↗ | |
| See Remarks | Sale | 15,448 | $3.2M | Sep 14 | — | SEC ↗ | |
| Director | Sale | 17,090 | $3.6M | Sep 10 | — | SEC ↗ | |
Kim Lorence H.First filing | Director | Sale | 56,000 | $11.4M | Sep 2 | — | SEC ↗ |
| General Counsel | Sale | 56,894 | $11.9M | Aug 25 | — | SEC ↗ | |
| See Remarks | Sale | 86,000 | $18.0M | Aug 25 | — | SEC ↗ | |
| Director | Sale | 5,580 | $1.0M | Jul 1 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 20,000 | $3.4M | Jun 26 | — | SEC ↗ | |
| See Remarks | Sale | 10,020 | $1.6M | Jun 18 | — | SEC ↗ | |
Anders JackFirst in 3 months | Chief Financial Officer | Sale | 2,722 | $425K | Jun 18 | — | SEC ↗ |
Cislini JeffFirst in 3 months | General Counsel | Sale | 2,157 | $337K | Jun 18 | — | SEC ↗ |
| See Remarks | Sale | 4,615 | $720K | Jun 18 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does RVMD have?
Revolution Medicines, Inc. (RVMD) has 69 SEC Form 4 filings (215 transaction rows) in the rolling 365-day window, disclosed by 12 distinct insiders. Most recent filing: Oct 1, 2026.
When was the most recent SEC Form 4 filing for RVMD?
The most recent Form 4 filing for RVMD on Tracefour is dated Oct 1, 2026.
Who is the most active insider at RVMD?
The most active SEC Form 4 filer at RVMD in the rolling window is See Remarks GOLDSMITH MARK A, with 11 filings.
What is the net insider flow at RVMD over the last 6 months?
Over the trailing 180 days, insiders at RVMD have net sold $121.5M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at RVMD in the current window?
Inside the rolling window, insiders at RVMD bought $0 and sold $154.1M based on SEC Form 4 filings.
Can I get alerts for RVMD insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Revolution Medicines, Inc. (RVMD). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Revolution Medicines, Inc. is in the Healthcare sector.